跳至主要内容
临床试验/NCT01826409
NCT01826409已完成2 期

Hypoglycemic Effects of Fermented Red Ginseng in Subject With Impaired Fasting Glucose or Type 2 Diabetes

Chonbuk National University Hospital1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2008年3月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
42
试验地点
1
主要终点
Glucose profiles during meal tolerance test

研究概览

简要总结

This study was conducted to investigate the effects of daily supplementation of fermented red ginseng (FRG) on glycemic status in subjects with impaired fasting glucose (IFG) or type 2 diabetes.

详细描述

This study was a 4 weeks, randomized, double-blind, placebo-controlled trial. Forty-two subjects with IFG or type 2 diabetes were randomly allocated to 2 groups to consume placebo or FRG three times per day for 4 weeks. Fasting and postprandial glucose profiles during meal tolerance test were assessed before and after the intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 20-75 years with fasting glucose 100~140 mg/dL at least two of the following

排除标准

  • •Lipid metabolic disorder
  • •Acute or chronic inflammatory disease
  • •Taking medication of corticosteroid within 4 weeks of the study
  • •Cardiovascular disease (arrhythmia, heart failure, myocardial infarction or patient with pacemaker)
  • •Allergic or hypersensitive to any of the ingredients in the test products
  • •Participation in other clinical trials within 2 months
  • •Abnormal hepatic liver function or renal disease (acute/chronic renal failure or nephrotic syndrome)
  • •Taking medication of lipid phosphates within 3 months of the study etc,

研究组 & 干预措施

Fermented red ginseng

Experimental

干预措施: Fermented Red Ginseng (Dietary Supplement)

Placebo

Placebo Comparator

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Glucose profiles during meal tolerance test

时间窗: 4 weeks

Fasting and postprandial glucose profiles during meal tolerance test were assessed before(baseline) and after the intervention

次要结局

  • Change in lipid profiles(4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Soo-Wan Chae

Principal Investigator, Clinical Trial Center for Functional Foods

Chonbuk National University Hospital

研究点 (1)

Loading locations...

相似试验